SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Clinical Stage Biotechnology Companysynactpharma.com
Oversigt
- 5–9
- Medarbejdere
- 5–10mio SEK
- Omsætning
- 2016
- Grundlagt
Nøglebeslutningstagere
Björn Westberg
Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen, PhD.
Chief Operating Officer
Sten Sørensen
Board Member
+6 flere kontakter i Funnelfeedr
Beskrivelse
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...